tirzepatide ncbi The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity Tirzepatide for Weight Loss (Fat

[7] [9] Lifestyle factors substantially modulate treatment response

Conflict of interest The authors declare no conflict of interest.

2018 Mar;46:76-82

Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM

Image Credit: zimmytws / Shutterstock A recent review published in The Nurse Practitioner highlights the expanding clinical role of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have also drawn widespread media attention for their rapid weight-loss effects

Tirzepatide belongs to a class of medications known as dual GIP/GLP-1 receptor agonists, meaning it works on two key hormones that influence appetite and blood sugar control